Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Paris

Showing results (71-80 of 81) with videos related to

Pageof 9
Sort By:
Retina (Philadelphia, Pa.)|August 25, 2021
ReplyJeffrey S Heier, Rishi P Singh, Charles C Wykoff, et al.
PNAS Nexus|March 13, 2023
The first genetic landscape of inherited retinal dystrophies in Portuguese patients identifies recurrent homozygous mutations as a frequent cause of pathogenesisVirginie G Peter, Karolina Kaminska, Cristina Santos, et al.
SAR and QSAR in Environmental Research|May 12, 2016
Results of a round-robin exercise on read-acrossE Benfenati, M Belli, T Borges, et al.
International Journal of Cosmetic Science|November 11, 2018
Effect of zein additive on perfume evaporationA Cabin-Flaman, A Delaune, P Poutrain, et al.
International Immunopharmacology|January 22, 2013
3-Phenylcoumarin derivatives selectively modulate different steps of reactive oxygen species production by immune complex-stimulated human neutrophilsMicássio F Andrade, Luciana M Kabeya, Ana Elisa C S Azzolini, et al.
Ophthalmology Science|October 9, 2023
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and RationaleLars-Olof Hattenbach, Francis Abreu, Pablo Arrisi, et al.
Ophthalmology. Retina|March 19, 2025
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO TrialsCarl J Danzig, Christiana Dinah, Faruque Ghanchi, et al.
Ophthalmology|January 27, 2024
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO TrialsRamin Tadayoni, Liliana P Paris, Carl J Danzig, et al.
Metabolomics : Official Journal of the Metabolomic Society|December 1, 2015
Global metabolomics reveals metabolic dysregulation in ischemic retinopathyLiliana P Paris, Caroline H Johnson, Edith Aguilar, et al.
Plos Genetics|August 20, 2019
Mutations in ARL2BP, a protein required for ciliary microtubule structure, cause syndromic male infertility in humans and miceAbigail R Moye, Nicola Bedoni, Jessica G Cunningham, et al.
Pageof 9

Showing results (71-80 of 81) with videos related to

Sort By:
Pageof 9
Retina (Philadelphia, Pa.)|August 25, 2021
ReplyJeffrey S Heier, Rishi P Singh, Charles C Wykoff, et al.
PNAS Nexus|March 13, 2023
The first genetic landscape of inherited retinal dystrophies in Portuguese patients identifies recurrent homozygous mutations as a frequent cause of pathogenesisVirginie G Peter, Karolina Kaminska, Cristina Santos, et al.
SAR and QSAR in Environmental Research|May 12, 2016
Results of a round-robin exercise on read-acrossE Benfenati, M Belli, T Borges, et al.
International Journal of Cosmetic Science|November 11, 2018
Effect of zein additive on perfume evaporationA Cabin-Flaman, A Delaune, P Poutrain, et al.
International Immunopharmacology|January 22, 2013
3-Phenylcoumarin derivatives selectively modulate different steps of reactive oxygen species production by immune complex-stimulated human neutrophilsMicássio F Andrade, Luciana M Kabeya, Ana Elisa C S Azzolini, et al.
Ophthalmology Science|October 9, 2023
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and RationaleLars-Olof Hattenbach, Francis Abreu, Pablo Arrisi, et al.
Ophthalmology. Retina|March 19, 2025
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO TrialsCarl J Danzig, Christiana Dinah, Faruque Ghanchi, et al.
Ophthalmology|January 27, 2024
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO TrialsRamin Tadayoni, Liliana P Paris, Carl J Danzig, et al.
Metabolomics : Official Journal of the Metabolomic Society|December 1, 2015
Global metabolomics reveals metabolic dysregulation in ischemic retinopathyLiliana P Paris, Caroline H Johnson, Edith Aguilar, et al.
Plos Genetics|August 20, 2019
Mutations in ARL2BP, a protein required for ciliary microtubule structure, cause syndromic male infertility in humans and miceAbigail R Moye, Nicola Bedoni, Jessica G Cunningham, et al.
Pageof 9